Skip to main content
Log in

Commentary: considering radiomics in the setting of prostate cancer active surveillance

  • Commentary
  • Published:
European Radiology Aims and scope Submit manuscript

The Original Article was published on 07 February 2023

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Lambin P, Leijenaar RTH, Deist TM et al (2017) Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol 14(12):749–762

    Article  PubMed  Google Scholar 

  2. Smith CP, Czarniecki M, Mehralivand S et al (2019) Radiomics and radiogenomics of prostate cancer. Abdom Radiol (NY) 44(6):2021–2029

    Article  PubMed  Google Scholar 

  3. Sushentsev N, Rundo L, Abrego L et al (2023) Time series radiomics for the prediction of prostate cancer progression in patients on active surveillance. Eur Radiol. https://doi.org/10.1007/s00330-023-09438-x

  4. Sushentsev N, Rundo L, Blyuss O et al (2021) MRI-derived radiomics model for baseline prediction of prostate cancer progression on active surveillance. Sci Rep 11(1):12917

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Sushentsev N, Rundo L, Blyuss O et al (2022) Comparative performance of MRI-derived PRECISE scores and delta-radiomics models for the prediction of prostate cancer progression in patients on active surveillance. Eur Radiol 32(1):680–689

    Article  PubMed  Google Scholar 

  6. Walker CH, Marchetti KA, Singhal U, Morgan TM (2022) Active surveillance for prostate cancer: selection criteria, guidelines, and outcomes. World J Urol 40(1):35–42

    Article  PubMed  Google Scholar 

  7. Moore CM, Giganti F, Albertsen P et al (2017) Reporting magnetic resonance imaging in men on active surveillance for prostate cancer: the PRECISE recommendations-a report of a European School of Oncology Task Force. Eur Urol 71(4):648–655

    Article  PubMed  Google Scholar 

  8. Rajwa P, Pradere B, Quhal F et al (2021) Reliability of serial prostate magnetic resonance imaging to detect prostate cancer progression during active surveillance: a systematic review and meta-analysis. Eur Urol 80(5):549–563

    Article  PubMed  Google Scholar 

  9. Caglic I, Sushentsev N, Gnanapragasam VJ et al (2021) MRI-derived PRECISE scores for predicting pathologically-confirmed radiological progression in prostate cancer patients on active surveillance. Eur Radiol 31(5):2696–2705

    Article  PubMed  Google Scholar 

Download references

Funding

The authors state that this work has not received any funding.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sonia Gaur.

Ethics declarations

Guarantor

The scientific guarantor of this publication is Sonia Gaur.

Conflict of interest

Sonia Gaur, MD, reports royalties from the National Institutes of Health for licensed intellectual property in artificial intelligence technology in prostate MRI.

Statistics and biometry

No complex statistical methods were necessary for this paper.

Informed consent

NA

Ethical approval

NA

Study subjects or cohorts overlap

NA

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This comment refers to the article available at https://doi.org/10.1007/s00330-023-09438-x

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gaur, S. Commentary: considering radiomics in the setting of prostate cancer active surveillance. Eur Radiol 33, 3789–3791 (2023). https://doi.org/10.1007/s00330-023-09634-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-023-09634-9

Navigation